{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T15:42:56Z","timestamp":1763480576581,"version":"3.37.3"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Protein J"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s10930-022-10056-7","type":"journal-article","created":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T07:02:46Z","timestamp":1654066966000},"page":"361-368","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Neglected N-Truncated Amyloid-\u03b2 Peptide and Its Mixed Cu\u2013Zn Complexes"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2084-3446","authenticated-orcid":false,"given":"Tomasz","family":"Fr\u0105czyk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0700-5691","authenticated-orcid":false,"given":"Piotr","family":"Cieplak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,1]]},"reference":[{"key":"10056_CR1","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.0959-9673.2005.00434.x","volume":"86","author":"CJ Maynard","year":"2005","unstructured":"Maynard CJ, Bush AI, Masters CL et al (2005) Metals and amyloid-\u03b2 in Alzheimer\u2019s disease. Int J Exp Pathol 86:147\u2013159. https:\/\/doi.org\/10.1111\/j.0959-9673.2005.00434.x","journal-title":"Int J Exp Pathol"},{"key":"10056_CR2","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.conb.2020.02.003","volume":"61","author":"DM Walsh","year":"2020","unstructured":"Walsh DM, Selkoe DJ (2020) Amyloid \u03b2-protein and beyond: the path forward in Alzheimer\u2019s disease. Curr Opin Neurobiol 61:116\u2013124. https:\/\/doi.org\/10.1016\/j.conb.2020.02.003","journal-title":"Curr Opin Neurobiol"},{"key":"10056_CR3","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3389\/fnins.2017.00317","volume":"11","author":"SC Drew","year":"2017","unstructured":"Drew SC (2017) The case for abandoning therapeutic chelation of copper ions in Alzheimer\u2019s disease. Front Neurosci 11:317. https:\/\/doi.org\/10.3389\/fnins.2017.00317","journal-title":"Front Neurosci"},{"key":"10056_CR4","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.pneurobio.2016.06.004","volume":"143","author":"KP Kepp","year":"2016","unstructured":"Kepp KP (2016) Alzheimer\u2019s disease due to loss of function: a new synthesis of the available data. Prog Neurobiol 143:36\u201360. https:\/\/doi.org\/10.1016\/j.pneurobio.2016.06.004","journal-title":"Prog Neurobiol"},{"key":"10056_CR5","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.REV120.008207","volume":"296","author":"P Lei","year":"2021","unstructured":"Lei P, Ayton S, Bush AI (2021) The essential elements of Alzheimer\u2019s disease. J Biol Chem 296:100105. https:\/\/doi.org\/10.1074\/jbc.REV120.008207","journal-title":"J Biol Chem"},{"key":"10056_CR6","doi-asserted-by":"publisher","first-page":"12193","DOI":"10.1021\/ic4003059","volume":"52","author":"P Faller","year":"2013","unstructured":"Faller P, Hureau C, Berthoumieu O (2013) Role of metal ions in the self-assembly of the Alzheimer\u2019s amyloid-\u03b2 peptide. Inorg Chem 52:12193\u201312206. https:\/\/doi.org\/10.1021\/ic4003059","journal-title":"Inorg Chem"},{"key":"10056_CR7","doi-asserted-by":"crossref","unstructured":"Wolfe MS (2019) In search of pathogenic amyloid \u03b2-peptide in familial Alzheimer\u2019s disease. In: Progress in Molecular Biology and Translational Science, 1st ed. Elsevier Inc., pp 71\u201378","DOI":"10.1016\/bs.pmbts.2019.07.002"},{"key":"10056_CR8","doi-asserted-by":"publisher","first-page":"4245","DOI":"10.1073\/pnas.82.12.4245","volume":"82","author":"CL Masters","year":"1985","unstructured":"Masters CL, Simms G, Weinman NA et al (1985) Amyloid plaque core protein in Alzheimer disease and down syndrome. Proc Natl Acad Sci U S A 82:4245\u20134249. https:\/\/doi.org\/10.1073\/pnas.82.12.4245","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10056_CR9","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1006\/abbi.1993.1112","volume":"301","author":"DL Miller","year":"1993","unstructured":"Miller DL, Papayannopoulos IA, Styles J et al (1993) Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer\u2032s Disease. Arch Biochem Biophys 301:41\u201352","journal-title":"Arch Biochem Biophys"},{"key":"10056_CR10","doi-asserted-by":"publisher","first-page":"8378","DOI":"10.1073\/pnas.91.18.8378","volume":"91","author":"J Naslund","year":"1994","unstructured":"Naslund J, Schierhorn A, Hellman U et al (1994) Relative abundance of Alzheimer A\u03b2 amyloid peptide variants in Alzheimer disease and normal aging. Proc Natl Acad Sci 91:8378\u20138382. https:\/\/doi.org\/10.1073\/pnas.91.18.8378","journal-title":"Proc Natl Acad Sci"},{"key":"10056_CR11","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/j.1365-2990.2006.00696.x","volume":"32","author":"H Lewis","year":"2006","unstructured":"Lewis H, Beher D, Cookson N et al (2006) Quantification of Alzheimer pathology in ageing and dementia: Age-related accumulation of amyloid-\u03b2(42) peptide in vascular dementia. Neuropathol Appl Neurobiol 32:103\u2013118. https:\/\/doi.org\/10.1111\/j.1365-2990.2006.00696.x","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10056_CR12","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s00401-010-0690-1","volume":"120","author":"E Portelius","year":"2010","unstructured":"Portelius E, Bogdanovic N, Gustavsson MK et al (2010) Mass spectrometric characterization of brain amyloid beta isoform signatures in familial and sporadic Alzheimer\u2019s disease. Acta Neuropathol 120:185\u2013193. https:\/\/doi.org\/10.1007\/s00401-010-0690-1","journal-title":"Acta Neuropathol"},{"key":"10056_CR13","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/alzrt121","volume":"4","author":"BD Moore","year":"2012","unstructured":"Moore BD, Chakrabarty P, Levites Y et al (2012) Overlapping profiles of Abeta peptides in the Alzheimer\u2019s disease and pathological aging brains. Alzheimers Res Ther 4:18. https:\/\/doi.org\/10.1186\/alzrt121","journal-title":"Alzheimers Res Ther"},{"key":"10056_CR14","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.1093\/brain\/awu255","volume":"137","author":"SK Fritschi","year":"2014","unstructured":"Fritschi SK, Langer F, Kaeser SA et al (2014) Highly potent soluble amyloid-\u03b2 seeds in human Alzheimer brain but not cerebrospinal fluid. Brain 137:2909\u20132915. https:\/\/doi.org\/10.1093\/brain\/awu255","journal-title":"Brain"},{"key":"10056_CR15","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1159\/000369465","volume":"15","author":"E Portelius","year":"2015","unstructured":"Portelius E, Lashley T, Westerlund A et al (2015) Brain amyloid-beta fragment signatures in pathological ageing and Alzheimer\u2019s disease by hybrid immunoprecipitation mass spectrometry. Neurodegener Dis 15:50\u201357. https:\/\/doi.org\/10.1159\/000369465","journal-title":"Neurodegener Dis"},{"key":"10056_CR16","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13195-017-0309-z","volume":"9","author":"O Wirths","year":"2017","unstructured":"Wirths O, Walter S, Kraus I et al (2017) N-truncated A\u03b24\u2212x peptides in sporadic Alzheimer\u2019s disease cases and transgenic Alzheimer mouse models. Alzheimer\u2019s Res Ther 9:80. https:\/\/doi.org\/10.1186\/s13195-017-0309-z","journal-title":"Alzheimer\u2019s Res Ther"},{"key":"10056_CR17","doi-asserted-by":"publisher","first-page":"9520","DOI":"10.1038\/s41598-017-10422-x","volume":"7","author":"NC Wildburger","year":"2017","unstructured":"Wildburger NC, Esparza TJ, Leduc RD et al (2017) Diversity of amyloid-beta proteoforms in the Alzheimer\u2019s disease brain. Sci Rep 7:9520. https:\/\/doi.org\/10.1038\/s41598-017-10422-x","journal-title":"Sci Rep"},{"key":"10056_CR18","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.bbadis.2017.07.005","volume":"1864","author":"E Cabrera","year":"2018","unstructured":"Cabrera E, Mathews P, Mezhericher E et al (2018) A\u03b2 truncated species: implications for brain clearance mechanisms and amyloid plaque deposition. Biochim Biophys Acta - Mol Basis Dis 1864:208\u2013225. https:\/\/doi.org\/10.1016\/j.bbadis.2017.07.005","journal-title":"Biochim Biophys Acta - Mol Basis Dis"},{"key":"10056_CR19","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.neulet.2019.02.033","volume":"701","author":"E Gkanatsiou","year":"2019","unstructured":"Gkanatsiou E, Portelius E, Toomey CE et al (2019) A distinct brain beta amyloid signature in cerebral amyloid angiopathy compared to Alzheimer\u2019s disease. Neurosci Lett 701:125\u2013131. https:\/\/doi.org\/10.1016\/j.neulet.2019.02.033","journal-title":"Neurosci Lett"},{"key":"10056_CR20","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1111\/nan.12637","volume":"46","author":"S Zampar","year":"2020","unstructured":"Zampar S, Klafki HW, Sritharen K et al (2020) N-terminal heterogeneity of parenchymal and vascular amyloid-\u03b2 deposits in Alzheimer\u2019s disease. Neuropathol Appl Neurobiol 46:673\u2013685. https:\/\/doi.org\/10.1111\/nan.12637","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10056_CR21","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcab028","author":"S Mukherjee","year":"2021","unstructured":"Mukherjee S, Perez KA, Lago LC et al (2021) Quantification of N-terminal amyloid-\u03b2 isoforms reveals isomers are the most abundant form of the amyloid-\u03b2 peptide in sporadic Alzheimer\u2019s disease. Brain Commun. https:\/\/doi.org\/10.1093\/braincomms\/fcab028","journal-title":"Brain Commun"},{"key":"10056_CR22","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1080\/07391102.2007.10507175","volume":"25","author":"L Shen","year":"2007","unstructured":"Shen L, Ji HF (2007) Rat\u2019s trick to escape Alzheimer\u2019s disease. J Biomol Struct Dyn 25:271\u2013273. https:\/\/doi.org\/10.1080\/07391102.2007.10507175","journal-title":"J Biomol Struct Dyn"},{"key":"10056_CR23","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1021\/jp075168m","volume":"112","author":"E Gaggelli","year":"2008","unstructured":"Gaggelli E, Janicka-Klos A, Jankowska E et al (2008) NMR studies of the Zn2+ interactions with rat and human \u03b2-amyloid (1\u201328) peptides in water-micelle environment. J Phys Chem B 112:100\u2013109. https:\/\/doi.org\/10.1021\/jp075168m","journal-title":"J Phys Chem B"},{"key":"10056_CR24","doi-asserted-by":"publisher","first-page":"14233","DOI":"10.1002\/chem.201802759","volume":"24","author":"B Alies","year":"2018","unstructured":"Alies B, Borghesani V, No\u00ebl S et al (2018) Mutations of histidine 13 to arginine and arginine 5 to glycine are responsible for different coordination sites of zinc(II) to human and murine peptides. Chem A Eur J 24:14233\u201314241. https:\/\/doi.org\/10.1002\/chem.201802759","journal-title":"Chem A Eur J"},{"key":"10056_CR25","doi-asserted-by":"crossref","unstructured":"Wirths O, Zampar S, Weggen S (2019) N-terminally truncated A\u03b2 peptide variants in Alzheimer\u2019s Disease. In: Alzheimer\u2019s disease. Codon Publications, pp 107\u2013122","DOI":"10.15586\/alzheimersdisease.2019.ch7"},{"key":"10056_CR26","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1111\/j.1471-4159.2009.06269.x","volume":"110","author":"V T\u00f5ugu","year":"2009","unstructured":"T\u00f5ugu V, Karafin A, Zovo K et al (2009) Zn(II)- and Cu(II)-induced non-fibrillar aggregates of amyloid-\u03b2 (1\u201342) peptide are transformed to amyloid fibrils, both spontaneously and under the influence of metal chelators. J Neurochem 110:1784\u20131795. https:\/\/doi.org\/10.1111\/j.1471-4159.2009.06269.x","journal-title":"J Neurochem"},{"key":"10056_CR27","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1021\/ja076282l","volume":"130","author":"D Noy","year":"2008","unstructured":"Noy D, Solomonov I, Sinkevich O et al (2008) Zinc-amyloid \u03b2 interactions on a millisecond time-scale stabilize non-fibrillar Alzheimer-related species. J Am Chem Soc 130:1376\u20131383. https:\/\/doi.org\/10.1021\/ja076282l","journal-title":"J Am Chem Soc"},{"key":"10056_CR28","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.3233\/JAD-2010-1338","volume":"19","author":"M Innocenti","year":"2010","unstructured":"Innocenti M, Salvietti E, Guidotti M et al (2010) Trace copper(II) or zinc(II) ions drastically modify the aggregation behavior of Amyloid-\u03b21-42: An AFM study. J Alzheimer\u2019s Dis 19:1323\u20131329. https:\/\/doi.org\/10.3233\/JAD-2010-1338","journal-title":"J Alzheimer\u2019s Dis"},{"key":"10056_CR29","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.biocel.2011.02.009","volume":"43","author":"S Bolognin","year":"2011","unstructured":"Bolognin S, Messori L, Drago D et al (2011) Aluminum, copper, iron and zinc differentially alter amyloid-A\u03b21-42 aggregation and toxicity. Int J Biochem Cell Biol 43:877\u2013885. https:\/\/doi.org\/10.1016\/j.biocel.2011.02.009","journal-title":"Int J Biochem Cell Biol"},{"key":"10056_CR30","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1039\/c3mt00161j","volume":"5","author":"AK Sharma","year":"2013","unstructured":"Sharma AK, Pavlova ST, Kim J et al (2013) The effect of Cu2+ and Zn2+ on the A\u03b242 peptide aggregation and cellular toxicity. Metallomics 5:1529. https:\/\/doi.org\/10.1039\/c3mt00161j","journal-title":"Metallomics"},{"key":"10056_CR31","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1016\/j.bpj.2011.06.062","volume":"101","author":"N Rezaei-Ghaleh","year":"2011","unstructured":"Rezaei-Ghaleh N, Giller K, Becker S, Zweckstetter M (2011) Effect of zinc binding on \u03b2-amyloid structure and dynamics: Implications for A\u03b2 aggregation. Biophys J 101:1202\u20131211. https:\/\/doi.org\/10.1016\/j.bpj.2011.06.062","journal-title":"Biophys J"},{"key":"10056_CR32","doi-asserted-by":"publisher","first-page":"6692","DOI":"10.1046\/j.1432-1327.2000.01767.x","volume":"267","author":"DS Yang","year":"2000","unstructured":"Yang DS, McLaurin J, Qin K et al (2000) Examining the zinc binding site of the amyloid-\u03b2 peptide. Eur J Biochem 267:6692\u20136698. https:\/\/doi.org\/10.1046\/j.1432-1327.2000.01767.x","journal-title":"Eur J Biochem"},{"key":"10056_CR33","doi-asserted-by":"publisher","first-page":"7024","DOI":"10.1021\/bi0002479","volume":"39","author":"T Miura","year":"2000","unstructured":"Miura T, Suzuki K, Kohata N, Takeuchi H (2000) Metal binding modes of Alzheimer\u2019s amyloid \u03b2-peptide in insoluble aggregates and soluble complexes. Biochemistry 39:7024\u20137031. https:\/\/doi.org\/10.1021\/bi0002479","journal-title":"Biochemistry"},{"key":"10056_CR34","doi-asserted-by":"publisher","first-page":"L84","DOI":"10.1016\/j.bpj.2010.09.015","volume":"99","author":"PO Tsvetkov","year":"2010","unstructured":"Tsvetkov PO, Kulikova AA, Golovin AV et al (2010) Minimal Zn2+ binding site of amyloid-\u03b2. Biophys J 99:L84\u2013L86. https:\/\/doi.org\/10.1016\/j.bpj.2010.09.015","journal-title":"Biophys J"},{"key":"10056_CR35","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1039\/c0mb00334d","volume":"7","author":"SA Kozin","year":"2011","unstructured":"Kozin SA, Mezentsev YV, Kulikova AA et al (2011) Zinc-induced dimerization of the amyloid-\u03b2 metal-binding domain 1\u201316 is mediated by residues 11\u201314. Mol Biosyst 7:1053\u20131055. https:\/\/doi.org\/10.1039\/c0mb00334d","journal-title":"Mol Biosyst"},{"key":"10056_CR36","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1021\/ic202247m","volume":"51","author":"B Alies","year":"2012","unstructured":"Alies B, Solari PL, Hureau C, Faller P (2012) Dynamics of ZnII binding as a key feature in the formation of amyloid fibrils by A\u03b211-28. Inorg Chem 51:701\u2013708. https:\/\/doi.org\/10.1021\/ic202247m","journal-title":"Inorg Chem"},{"key":"10056_CR37","doi-asserted-by":"publisher","first-page":"7897","DOI":"10.1021\/ic300972j","volume":"51","author":"B Alies","year":"2012","unstructured":"Alies B, LaPenna G, Sayen S et al (2012) Insights into the mechanisms of amyloid formation of ZnII -Ab11-28: pH-dependent zinc coordination and overall charge as key parameters for kinetics and the structure of ZnII -Ab11-28 aggregates. Inorg Chem 51:7897\u20137902. https:\/\/doi.org\/10.1021\/ic300972j","journal-title":"Inorg Chem"},{"key":"10056_CR38","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.bbapap.2005.09.012","volume":"1764","author":"CD Syme","year":"2006","unstructured":"Syme CD, Viles JH (2006) Solution 1H NMR investigation of Zn2+ and Cd 2+ binding to amyloid-beta peptide (A\u03b2) of Alzheimer\u2019s disease. Biochim Biophys Acta - Proteins Proteomics 1764:246\u2013256. https:\/\/doi.org\/10.1016\/j.bbapap.2005.09.012","journal-title":"Biochim Biophys Acta - Proteins Proteomics"},{"key":"10056_CR39","doi-asserted-by":"publisher","first-page":"13658","DOI":"10.1021\/bi701355j","volume":"46","author":"C Talmard","year":"2007","unstructured":"Talmard C, Bouzan A, Faller P (2007) Zinc binding to amyloid-\u03b2: Isothermal titration calorimetry and Zn competition experiments with Zn sensors. Biochemistry 46:13658\u201313666. https:\/\/doi.org\/10.1021\/bi701355j","journal-title":"Biochemistry"},{"key":"10056_CR40","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1074\/jbc.M504454200","volume":"281","author":"S Zirah","year":"2006","unstructured":"Zirah S, Kozin SA, Mazur AK et al (2006) Structural changes of region 1\u201316 of the Alzheimer disease amyloid \u03b2-peptide upon zinc binding and in vitro aging. J Biol Chem 281:2151\u20132161. https:\/\/doi.org\/10.1074\/jbc.M504454200","journal-title":"J Biol Chem"},{"key":"10056_CR41","doi-asserted-by":"publisher","first-page":"10499","DOI":"10.1021\/acs.inorgchem.6b01733","volume":"55","author":"B Alies","year":"2016","unstructured":"Alies B, Conte-Daban A, Sayen S et al (2016) Zinc(II) binding site to the amyloid-\u03b2 peptide: insights from spectroscopic studies with a wide series of modified peptides. Inorg Chem 55:10499\u201310509. https:\/\/doi.org\/10.1021\/acs.inorgchem.6b01733","journal-title":"Inorg Chem"},{"key":"10056_CR42","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1002\/cbic.200500057","volume":"6","author":"Y Mekmouche","year":"2005","unstructured":"Mekmouche Y, Coppel Y, Hochgr\u00e4fe K et al (2005) Characterization of the ZnII binding to the peptide amyloid-\u03b21-16 linked to Alzheimer\u2019s disease. ChemBioChem 6:1663\u20131671. https:\/\/doi.org\/10.1002\/cbic.200500057","journal-title":"ChemBioChem"},{"key":"10056_CR43","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1111\/j.1742-4658.2006.05563.x","volume":"274","author":"J Danielsson","year":"2007","unstructured":"Danielsson J, Pierattelli R, Banci L, Gr\u00e4slund A (2007) High-resolution NMR studies of the zinc-binding site of the Alzheimer\u2019s amyloid \u03b2-peptide. FEBS J 274:46\u201359. https:\/\/doi.org\/10.1111\/j.1742-4658.2006.05563.x","journal-title":"FEBS J"},{"key":"10056_CR44","doi-asserted-by":"publisher","first-page":"5407","DOI":"10.1073\/pnas.1421961112","volume":"112","author":"A Abelein","year":"2015","unstructured":"Abelein A, Gr\u00e4slund A, Danielsson J (2015) Zinc as chaperone-mimicking agent for retardation of amyloid \u03b2 peptide fibril formation. Proc Natl Acad Sci 112:5407\u20135412. https:\/\/doi.org\/10.1073\/pnas.1421961112","journal-title":"Proc Natl Acad Sci"},{"key":"10056_CR45","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/cbic.200600319","volume":"8","author":"C Talmard","year":"2007","unstructured":"Talmard C, Guilloreau L, Coppel Y et al (2007) Amyloid-beta peptide forms monomeric complexes with CuII and ZnII prior to aggregation. ChemBioChem 8:163\u2013165. https:\/\/doi.org\/10.1002\/cbic.200600319","journal-title":"ChemBioChem"},{"key":"10056_CR46","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1021\/acschemneuro.7b00121","volume":"8","author":"T Branch","year":"2017","unstructured":"Branch T, Barahona M, Dodson CA, Ying L (2017) Kinetic analysis reveals the identity of A\u03b2-metal complex responsible for the initial aggregation of A\u03b2 in the synapse. ACS Chem Neurosci 8:1970\u20131979. https:\/\/doi.org\/10.1021\/acschemneuro.7b00121","journal-title":"ACS Chem Neurosci"},{"key":"10056_CR47","doi-asserted-by":"publisher","first-page":"21734","DOI":"10.1038\/srep21734","volume":"6","author":"AN Istrate","year":"2016","unstructured":"Istrate AN, Kozin SA, Zhokhov SS et al (2016) Interplay of histidine residues of the Alzheimer\u2019s disease A\u03b2 peptide governs its Zn-induced oligomerization. Sci Rep 6:21734. https:\/\/doi.org\/10.1038\/srep21734","journal-title":"Sci Rep"},{"key":"10056_CR48","doi-asserted-by":"publisher","first-page":"4916","DOI":"10.1074\/jbc.M608220200","volume":"282","author":"Y Hori","year":"2007","unstructured":"Hori Y, Hashimoto T, Wakutani Y et al (2007) The Tottori (D7N) and English (H6R) familial Alzheimer disease mutations accelerate A\u03b2 fibril formation without increasing protofibril formation. J Biol Chem 282:4916\u20134923. https:\/\/doi.org\/10.1074\/jbc.M608220200","journal-title":"J Biol Chem"},{"key":"10056_CR49","doi-asserted-by":"publisher","first-page":"10784","DOI":"10.1074\/jbc.M707109200","volume":"283","author":"V Minicozzi","year":"2008","unstructured":"Minicozzi V, Stellato F, Comai M et al (2008) Identifying the minimal copper- and zinc-binding site sequence in amyloid-\u03b2 peptides. J Biol Chem 283:10784\u201310792. https:\/\/doi.org\/10.1074\/jbc.M707109200","journal-title":"J Biol Chem"},{"key":"10056_CR50","doi-asserted-by":"publisher","first-page":"13523","DOI":"10.1021\/bi701112z","volume":"46","author":"HL Kwang","year":"2007","unstructured":"Kwang HL, Yun KK, Chang YT (2007) Investigations of the molecular mechanism of metal-induced A\u03b2 (1\u201340) amyloidogenesis. Biochemistry 46:13523\u201313532. https:\/\/doi.org\/10.1021\/bi701112z","journal-title":"Biochemistry"},{"key":"10056_CR51","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1021\/acschemneuro.1c00072","volume":"12","author":"E Illes-Toth","year":"2021","unstructured":"Illes-Toth E, Meisl G, Rempel DL et al (2021) Pulsed hydrogen-deuterium exchange reveals altered structures and mechanisms in the aggregation of familial Alzheimer\u2019s disease mutants. ACS Chem Neurosci 12:1972\u20131982. https:\/\/doi.org\/10.1021\/acschemneuro.1c00072","journal-title":"ACS Chem Neurosci"},{"key":"10056_CR52","doi-asserted-by":"publisher","first-page":"961","DOI":"10.3390\/biom10060961","volume":"10","author":"SP Radko","year":"2020","unstructured":"Radko SP, Khmeleva SA, Kaluzhny DN et al (2020) The english (H6R) mutation of the Alzheimer\u2019s disease amyloid-\u03b2 peptide modulates its zinc-induced aggregation. Biomolecules 10:961. https:\/\/doi.org\/10.3390\/biom10060961","journal-title":"Biomolecules"},{"key":"10056_CR53","doi-asserted-by":"publisher","first-page":"2757","DOI":"10.1002\/j.1460-2075.1985.tb04000.x","volume":"4","author":"CL Masters","year":"1985","unstructured":"Masters CL, Multhaup G, Simms G et al (1985) Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer\u2019s disease contain the same protein as the amyloid of plaque cores and blood vessels. EMBO J 4:2757\u20132763. https:\/\/doi.org\/10.1002\/j.1460-2075.1985.tb04000.x","journal-title":"EMBO J"},{"key":"10056_CR54","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/2051-5960-1-56","volume":"1","author":"G Antonios","year":"2013","unstructured":"Antonios G, Saiepour N, Bouter Y et al (2013) N-truncated Abeta starting with position four: early intraneuronal accumulation and rescue of toxicity using NT4X-167, a novel monoclonal antibody. Acta Neuropathol Commun 1:56. https:\/\/doi.org\/10.1186\/2051-5960-1-56","journal-title":"Acta Neuropathol Commun"},{"key":"10056_CR55","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1046\/j.1471-4159.2003.01818.x","volume":"85","author":"N Sergeant","year":"2003","unstructured":"Sergeant N, Bombois S, Ghestem A et al (2003) Truncated beta-amyloid peptide species in pre-clinical Alzheimer\u2019s disease as new targets for the vaccination approach. J Neurochem 85:1581\u20131591. https:\/\/doi.org\/10.1046\/j.1471-4159.2003.01818.x","journal-title":"J Neurochem"},{"key":"10056_CR56","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1007\/s00401-015-1489-x","volume":"130","author":"Y Bouter","year":"2015","unstructured":"Bouter Y, Noguerola JSL, Tucholla P et al (2015) Abeta targets of the biosimilar antibodies of Bapineuzumab, Crenezumab, Solanezumab in comparison to an antibody against N-truncated Abeta in sporadic Alzheimer disease cases and mouse models. Acta Neuropathol 130:713\u2013729. https:\/\/doi.org\/10.1007\/s00401-015-1489-x","journal-title":"Acta Neuropathol"},{"key":"10056_CR57","doi-asserted-by":"publisher","first-page":"3301","DOI":"10.1093\/brain\/awx284","volume":"140","author":"M Shinohara","year":"2017","unstructured":"Shinohara M, Koga S, Konno T et al (2017) Distinct spatiotemporal accumulation of N-truncated and full-length amyloid-\u03b242 in Alzheimer\u2019s disease. Brain 140:3301\u20133316. https:\/\/doi.org\/10.1093\/brain\/awx284","journal-title":"Brain"},{"key":"10056_CR58","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s00401-014-1287-x","volume":"127","author":"TA Bayer","year":"2014","unstructured":"Bayer TA, Wirths O (2014) Focusing the amyloid cascade hypothesis on N-truncated Abeta peptides as drug targets against Alzheimer\u2019s disease. Acta Neuropathol 127:787\u2013801. https:\/\/doi.org\/10.1007\/s00401-014-1287-x","journal-title":"Acta Neuropathol"},{"key":"10056_CR59","doi-asserted-by":"publisher","first-page":"17342","DOI":"10.1073\/pnas.0506723102","volume":"102","author":"T Luhrs","year":"2005","unstructured":"Luhrs T, Ritter C, Adrian M et al (2005) 3D structure of Alzheimer\u2019s amyloid-\u03b2 (1\u201342) fibrils. Proc Natl Acad Sci 102:17342\u201317347. https:\/\/doi.org\/10.1073\/pnas.0506723102","journal-title":"Proc Natl Acad Sci"},{"key":"10056_CR60","doi-asserted-by":"publisher","first-page":"8830","DOI":"10.1039\/d0cc02463e","volume":"56","author":"L Cerofolini","year":"2020","unstructured":"Cerofolini L, Ravera E, Bologna S et al (2020) Mixing A\u03b2(1\u201340) and A\u03b2(1\u201342) peptides generates unique amyloid fibrils. Chem Commun 56:8830\u20138833. https:\/\/doi.org\/10.1039\/d0cc02463e","journal-title":"Chem Commun"},{"key":"10056_CR61","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1126\/science.aao2825","volume":"358","author":"L Gremer","year":"2017","unstructured":"Gremer L, Sch\u00f6lzel D, Schenk C et al (2017) Fibril structure of amyloid-\u03b2(1\u201342) by cryo\u2013electron microscopy. Science 358:116\u2013119. https:\/\/doi.org\/10.1126\/science.aao2825","journal-title":"Science"},{"key":"10056_CR62","doi-asserted-by":"publisher","first-page":"9663","DOI":"10.1021\/jacs.6b05129","volume":"138","author":"MT Colvin","year":"2016","unstructured":"Colvin MT, Silvers R, Ni QZ et al (2016) Atomic Resolution structure of monomorphic A\u03b242 amyloid fibrils. J Am Chem Soc 138:9663\u20139674. https:\/\/doi.org\/10.1021\/jacs.6b05129","journal-title":"J Am Chem Soc"},{"key":"10056_CR63","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/nsmb.2991","volume":"22","author":"Y Xiao","year":"2015","unstructured":"Xiao Y, Ma B, McElheny D et al (2015) A\u03b2(1\u201342) fibril structure illuminates self-recognition and replication of amyloid in Alzheimer\u2019s disease. Nat Struct Mol Biol 22:499\u2013505. https:\/\/doi.org\/10.1038\/nsmb.2991","journal-title":"Nat Struct Mol Biol"},{"key":"10056_CR64","doi-asserted-by":"publisher","first-page":"5342","DOI":"10.1021\/ic101537m","volume":"50","author":"CA Damante","year":"2011","unstructured":"Damante CA, \u00d6sz K, Nagy Z et al (2011) Zn2+\u2019s ability to alter the distribution of Cu2+ among the available binding sites of A\u03b2(1\u201316)-polyethylenglycol-ylated peptide: implications in Alzheimer\u2019s disease. Inorg Chem 50:5342\u20135350. https:\/\/doi.org\/10.1021\/ic101537m","journal-title":"Inorg Chem"},{"key":"10056_CR65","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1039\/c2cc38236a","volume":"49","author":"B Alies","year":"2013","unstructured":"Alies B, Sasaki I, Proux O et al (2013) Zn impacts Cu coordination to amyloid-\u03b2, the Alzheimer\u2019s peptide, but not the ROS production and the associated cell toxicity. Chem Commun 49:1214\u20131216. https:\/\/doi.org\/10.1039\/c2cc38236a","journal-title":"Chem Commun"},{"key":"10056_CR66","doi-asserted-by":"publisher","first-page":"10460","DOI":"10.1002\/anie.201502644","volume":"54","author":"M Mital","year":"2015","unstructured":"Mital M, Wezynfeld NE, Fr\u0105czyk T et al (2015) A functional role for A\u03b2 in metal homeostasis? N-truncation and high-affinity copper binding. Angew Chemie Int Ed 54:10460\u201310464. https:\/\/doi.org\/10.1002\/anie.201502644","journal-title":"Angew Chemie Int Ed"},{"key":"10056_CR67","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1021\/jm00012a007","volume":"38","author":"M Hahn","year":"1995","unstructured":"Hahn M (1995) Receptor surface models. 1 definition and construction. J Med Chem 38:2080\u20132090. https:\/\/doi.org\/10.1021\/jm00012a007","journal-title":"J Med Chem"},{"key":"10056_CR68","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1002\/jcc.20290","volume":"26","author":"DA Case","year":"2005","unstructured":"Case DA, Cheatham TE, Darden T et al (2005) The Amber biomolecular simulation programs. J Comput Chem 26:1668\u20131688. https:\/\/doi.org\/10.1002\/jcc.20290","journal-title":"J Comput Chem"},{"key":"10056_CR69","doi-asserted-by":"publisher","first-page":"3696","DOI":"10.1021\/acs.jctc.5b00255","volume":"11","author":"JA Maier","year":"2015","unstructured":"Maier JA, Martinez C, Kasavajhala K et al (2015) ff14SB: improving the accuracy of protein side chain and backbone parameters from ff99SB. J Chem Theory Comput 11:3696\u20133713. https:\/\/doi.org\/10.1021\/acs.jctc.5b00255","journal-title":"J Chem Theory Comput"},{"key":"10056_CR70","doi-asserted-by":"publisher","first-page":"4429","DOI":"10.1021\/acs.jctc.0c00194","volume":"16","author":"Z Li","year":"2020","unstructured":"Li Z, Song LF, Li P, Merz KM (2020) Systematic parametrization of divalent metal ions for the OPC3, OPC, TIP3P-FB, and TIP4P-FB water models. J Chem Theory Comput 16:4429\u20134442. https:\/\/doi.org\/10.1021\/acs.jctc.0c00194","journal-title":"J Chem Theory Comput"},{"key":"10056_CR71","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1002\/1097-0282(2000)56:4<275::AID-BIP10024>3.0.CO;2-E","volume":"56","author":"V Tsui","year":"2000","unstructured":"Tsui V, Case DA (2000) Theory and applications of the generalized born solvation model in macromolecular simulations. Biopolymers 56:275\u2013291. https:\/\/doi.org\/10.1002\/1097-0282(2000)56:4%3c275::AID-BIP10024%3e3.0.CO;2-E","journal-title":"Biopolymers"},{"key":"10056_CR72","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0044811","volume":"7","author":"RW Strange","year":"2012","unstructured":"Strange RW, Hough MA, Antonyuk SV, Hasnain SS (2012) Structural evidence for a copper-bound carbonate intermediate in the peroxidase and dismutase activities of superoxide dismutase. PLoS ONE 7:e44811. https:\/\/doi.org\/10.1371\/journal.pone.0044811","journal-title":"PLoS ONE"},{"key":"10056_CR73","doi-asserted-by":"publisher","first-page":"11234","DOI":"10.1002\/anie.202004264","volume":"59","author":"R Kotuniak","year":"2020","unstructured":"Kotuniak R, Strampraad MJF, Bossak-Ahmad K et al (2020) Key intermediate species reveal the copper(II)-exchange pathway in biorelevant ATCUN\/NTS complexes. Angew Chemie Int Ed 59:11234\u201311239. https:\/\/doi.org\/10.1002\/anie.202004264","journal-title":"Angew Chemie Int Ed"},{"key":"10056_CR74","doi-asserted-by":"publisher","first-page":"3311","DOI":"10.1021\/ic050018g","volume":"44","author":"V Pelmenschikov","year":"2005","unstructured":"Pelmenschikov V, Siegbahn PEM (2005) Copper\u2212zinc superoxide dismutase: theoretical insights into the catalytic mechanism. Inorg Chem 44:3311\u20133320. https:\/\/doi.org\/10.1021\/ic050018g","journal-title":"Inorg Chem"},{"key":"10056_CR75","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/cbic.200500223","volume":"7","author":"S Tomaselli","year":"2006","unstructured":"Tomaselli S, Esposito V, Vangone P et al (2006) The \u03b1-to-\u03b2 conformational transition of Alzheimer\u2019s A\u03b2-(1\u201342) peptide in aqueous media is reversible: a step by step conformational analysis suggests the location of \u03b2 conformation seeding. ChemBioChem 7:257\u2013267. https:\/\/doi.org\/10.1002\/cbic.200500223","journal-title":"ChemBioChem"},{"key":"10056_CR76","doi-asserted-by":"publisher","first-page":"732","DOI":"10.3390\/ph14080732","volume":"14","author":"A Santoro","year":"2021","unstructured":"Santoro A, Grimaldi M, Buonocore M et al (2021) Exploring the early stages of the amyloid A\u03b2(1\u201342) peptide aggregation process: an NMR study. Pharmaceuticals 14:732. https:\/\/doi.org\/10.3390\/ph14080732","journal-title":"Pharmaceuticals"},{"key":"10056_CR77","doi-asserted-by":"publisher","first-page":"11253","DOI":"10.1073\/pnas.1818530116","volume":"116","author":"Z-W Hu","year":"2019","unstructured":"Hu Z-W, Vugmeyster L, Au DF et al (2019) Molecular structure of an N-terminal phosphorylated \u03b2-amyloid fibril. Proc Natl Acad Sci 116:11253\u201311258. https:\/\/doi.org\/10.1073\/pnas.1818530116","journal-title":"Proc Natl Acad Sci"},{"key":"10056_CR78","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.sbi.2020.12.002","volume":"66","author":"ES Choi","year":"2021","unstructured":"Choi ES, Dokholyan NV (2021) SOD1 oligomers in amyotrophic lateral sclerosis. Curr Opin Struct Biol 66:225\u2013230. https:\/\/doi.org\/10.1016\/j.sbi.2020.12.002","journal-title":"Curr Opin Struct Biol"},{"key":"10056_CR79","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.bbrc.2017.08.127","volume":"493","author":"J-Y Jang","year":"2017","unstructured":"Jang J-Y, Cho H, Park H-Y et al (2017) ALS-linked mutant SOD1 proteins promote A\u03b2 aggregates in ALS through direct interaction with A\u03b2. Biochem Biophys Res Commun 493:697\u2013707. https:\/\/doi.org\/10.1016\/j.bbrc.2017.08.127","journal-title":"Biochem Biophys Res Commun"},{"key":"10056_CR80","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1517\/14728222.2015.1029454","volume":"19","author":"A Takeda","year":"2015","unstructured":"Takeda A, Tamano H (2015) Regulation of extracellular Zn2+ homeostasis in the hippocampus as a therapeutic target for Alzheimer\u2019s disease. Expert Opin Ther Targets 19:1051\u20131058. https:\/\/doi.org\/10.1517\/14728222.2015.1029454","journal-title":"Expert Opin Ther Targets"},{"key":"10056_CR81","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1016\/j.jmb.2019.01.018","volume":"431","author":"TJ Huat","year":"2019","unstructured":"Huat TJ, Camats-Perna J, Newcombe EA et al (2019) Metal toxicity links to Alzheimer\u2019s disease and neuroinflammation. J Mol Biol 431:1843\u20131868. https:\/\/doi.org\/10.1016\/j.jmb.2019.01.018","journal-title":"J Mol Biol"},{"key":"10056_CR82","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.jinorgbio.2016.02.035","volume":"158","author":"T Fr\u0105czyk","year":"2016","unstructured":"Fr\u0105czyk T, Zawisza IA, Goch W et al (2016) On the ability of CuA\u03b21\u2212x peptides to form ternary complexes: neurotransmitter glutamate is a competitor while not a ternary partner. J Inorg Biochem 158:5\u201310. https:\/\/doi.org\/10.1016\/j.jinorgbio.2016.02.035","journal-title":"J Inorg Biochem"},{"key":"10056_CR83","doi-asserted-by":"publisher","first-page":"3639","DOI":"10.3390\/jcm10163639","volume":"10","author":"L Montoliu-Gaya","year":"2021","unstructured":"Montoliu-Gaya L, Strydom A, Blennow K et al (2021) Blood biomarkers for Alzheimer\u2019s disease in down syndrome. J Clin Med 10:3639. https:\/\/doi.org\/10.3390\/jcm10163639","journal-title":"J Clin Med"},{"key":"10056_CR84","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2018.00053","author":"S Daniele","year":"2018","unstructured":"Daniele S, Frosini D, Pietrobono D et al (2018) \u03b1-Synuclein heterocomplexes with \u03b2-amyloid are increased in red blood cells of parkinson\u2019s disease patients and correlate with disease severity. Front Mol Neurosci. https:\/\/doi.org\/10.3389\/fnmol.2018.00053","journal-title":"Front Mol Neurosci"},{"key":"10056_CR85","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","volume":"14","author":"W Humphrey","year":"1996","unstructured":"Humphrey W, Dalke A, Schulten K (1996) VMD: visual molecular dynamics. J Mol Graph 14:33\u201338. https:\/\/doi.org\/10.1016\/0263-7855(96)00018-5","journal-title":"J Mol Graph"}],"container-title":["The Protein Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10930-022-10056-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10930-022-10056-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10930-022-10056-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T00:40:01Z","timestamp":1667522401000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10930-022-10056-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":85,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["10056"],"URL":"https:\/\/doi.org\/10.1007\/s10930-022-10056-7","relation":{},"ISSN":["1572-3887","1875-8355"],"issn-type":[{"type":"print","value":"1572-3887"},{"type":"electronic","value":"1875-8355"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"10 May 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Authors have no conflicts of interest to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}